前收市價 | 43.01 |
開市 | 43.15 |
買盤 | 43.09 x 100 |
賣出價 | 43.14 x 100 |
今日波幅 | 42.63 - 43.62 |
52 週波幅 | 34.32 - 54.44 |
成交量 | |
平均成交量 | 1,079,242 |
市值 | 6.285B |
Beta 值 (5 年,每月) | 0.40 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -2.56 |
業績公佈日 | 2024年5月07日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 55.95 |
4D Molecular Therapeutics (FDMT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ionis Pharmaceuticals (IONS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ionis' (IONS) collaboration revenues enable it to invest in its wholly-owned pipeline. This is expected to enhance Ionis' already diverse revenue streams.